Skip to main content
. 2011 Dec 5;2011:125271. doi: 10.4061/2011/125271

Table 4.

The distribution of antiparkinsonian therapy used in the patients studied.

Therapies Patients (n) Percent (%)
Drug naïve 12 8.89
Levodopa monotherapy 50 37.04
DA monotherapy 11 8.15
Levodopa + DA 61 45.19
Others 1 0.74

DA: dopamine agonists.